Fed. Circ. Affirms Mylan Infringed Overdose Drug Patent
The Federal Circuit Thursday ruled Mylan Institutional LLC infringed Tennessee drugmaker Cumberland Pharmaceuticals Inc.'s patent for the overdose treatment Acetadote with its application for a generic, affirming that Cumberland's formula was...To view the full article, register now.
Already a subscriber? Click here to view full article